Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Early and severe: Kids hit hard by 2022-23 flu season, vaccination rates drop

The 2022-23 influenza season saw a highly severe impact on U.S. adolescents and children, with early peaks in hospitalization rates and outpatient visits. The study underscores the importance of flu vaccination and antiviral treatment, especially as fewer hospitalized children were vaccinated compared to previous seasons.

15 Oct 2023

Are people with HIV at a higher risk of severe COVID-19 outcomes?

The research review indicates that people with HIV, especially those with low CD4 cell counts, face greater risks of severe COVID-19 outcomes and have suboptimal immune responses to SARS-CoV-2. Antiretroviral therapy aids in clearing infections, and a third vaccine dose reduces the risk of breakthrough infections among this population.

15 Oct 2023

Moderna's updated COVID-19 vaccine for Autumn 2023 outperforms in cost and clinical impact

Moderna's updated mRNA-1273.815 COVID-19 vaccine shows promising results in reducing symptomatic cases, hospitalizations, and deaths in high-risk and older adults in Germany. The study finds the vaccine to be more cost-effective and clinically beneficial than both no vaccination and Pfizer's XBB.1.5 BNT162b2 vaccine.

12 Oct 2023

EVScape: New tool to forecast which SARS-CoV-2 variants could dodge our immunity

Researchers have developed EVScape, a predictive tool that identifies which SARS-CoV-2 strains are most likely to evade host immunity. Utilizing a deep generative model and structural information, the tool offers early warning about viral variants, aiding in the timely development of effective vaccines and treatments.

12 Oct 2023

Healthcare settings and mpox transmission: Understanding the risk factors

The stability of the monkeypox (Mpox) virus in various surroundings and bodily fluid.

12 Oct 2023

Adaptability and promising potential of synthetic information in healthcare

The possible benefits and limits of artificially generated data in the context of healthcare analytics.

11 Oct 2023

Inflammatory diseases don't boost clotting risks post-COVID, study reveals

Canadian researchers found that patients with immune-mediated inflammatory diseases (IMIDs) don't face a heightened risk of venous thromboembolism events after recovering from COVID-19 compared to those without IMIDs. However, certain comorbidities can influence this risk, emphasizing the importance of individualized patient care.

11 Oct 2023

SARS-CoV-2 RNA found in ocular tissues at autopsy, despite minimal inflammation

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), infects tissues throughout the human body, including the eye.

10 Oct 2023

Comparing the lasting effects: post COVID vs. non-COVID acute respiratory infections

Symptom profiles between individuals with prior COVID-19 and those with other acute respiratory infections (ARIs).

10 Oct 2023

COVID-19 heightens risk of autoimmune disorders

SARS-CoV-2 infection may elevate risk for certain autoimmune disorders, suggests study. Regular post-COVID monitoring needed to detect and manage potential autoimmune consequences.

9 Oct 2023

Breast milk microbiome changes after COVID-19 vaccination, linked to enhanced infant protection

Study explored the association between BNT162b2 vaccine-induced antibodies and the breast milk microbiome in 49 breastfeeding mothers, revealing that post-vaccination alterations in the microbiome were linked to humoral protection against SARS-CoV-2.

9 Oct 2023

Next-gen intranasal vaccine takes on measles, mumps, and multiple COVID-19 variants in one shot

Researchers developed an intranasal trivalent measles-mumps-SARS-CoV-2 vaccine that provides robust protection against multiple coronavirus variants. Leveraging the established measles-mumps-rubella platform, this vaccine demonstrates broad and adaptable immune responses, especially against Delta and Omicron variants.

8 Oct 2023

Antigenic cartography decodes the mysteries of SARS-CoV-2 variants and vaccines

Using antigenic cartography, researchers analyzed cross-reactivity patterns of SARS-CoV-2 variants and the effect of spike-protein changes on post-infection and vaccination immune responses. The study illuminated unique neutralization profiles and underscored the evolving defense mechanisms with repeated immunizations.

8 Oct 2023

Decoding the twist: Coronavirus spike proteins reveal their intricate invasion dance

Researchers use cryo-EM and molecular dynamics to reveal conformational changes in the spike proteins of human coronavirus HKU1 upon binding with a receptor. Findings unveil the complexity of beta coronavirus attachment, suggesting a more intricate mechanism of host cell invasion than previously understood.

8 Oct 2023

Novavax vaccine shows resilient defense against symptomatic COVID-19 despite Omicron challenge

Recent study assesses NVX-CoV2373 vaccine's effectiveness against Omicron variant. Findings show decreased efficacy over four months, but stable protection against symptomatic COVID-19.

8 Oct 2023

COVID-19's ripple effect: South African TB diagnostics take a hit

COVID-19 disrupts TB diagnostic services in South Africa's primary health clinics, highlighting the need for robust systems resilient to future pandemics.

8 Oct 2023

Nirmatrelvir and ritonavir combo cuts COVID-19 risks for high-vulnerability groups

Nirmatrelvir and ritonavir treatment significantly reduces the risk of hospitalization and death from COVID-19 in high-risk individuals, according to a recent JAMA Network Open study. However, the treatment's efficacy varied based on the degree of vulnerability, emphasizing tailored approaches for different risk groups.

8 Oct 2023

Protein recombinant vaccine NVX-CoV2373 confers protection during Omicron dominant period in Italy

The NVX-CoV2373 COVID-19 vaccine offers significant protection against symptomatic infections, but its effectiveness against SARS-CoV-2 declines within four months, according to a study in JAMA Network Open using Italian data. However, its protection against symptomatic COVID-19 seems to remain stable during this period.

8 Oct 2023

Inhaled nitric oxide shows promise as treatment for COVID-19 respiratory failure

Inhaled nitric oxide gas widens blood vessels in the lungs and is used to treat severe cardio-pulmonary conditions in newborns and adults.

6 Oct 2023

Why are most Americans skipping the COVID-19 booster?

A study in the journal Vaccine reveals that misinformation and concerns about side effects are leading reasons why over 80% of eligible Americans have skipped the SARS-CoV-2 vaccine booster. The research underscores the need for more public education about the vaccine's benefits in combating severe COVID-19 infections.

5 Oct 2023

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Early and severe: Kids hit hard by 2022-23 flu season, vaccination rates drop

Are people with HIV at a higher risk of severe COVID-19 outcomes?

Moderna's updated COVID-19 vaccine for Autumn 2023 outperforms in cost and clinical impact

EVScape: New tool to forecast which SARS-CoV-2 variants could dodge our immunity

Healthcare settings and mpox transmission: Understanding the risk factors

Adaptability and promising potential of synthetic information in healthcare

Inflammatory diseases don't boost clotting risks post-COVID, study reveals

SARS-CoV-2 RNA found in ocular tissues at autopsy, despite minimal inflammation

Comparing the lasting effects: post COVID vs. non-COVID acute respiratory infections

COVID-19 heightens risk of autoimmune disorders

Breast milk microbiome changes after COVID-19 vaccination, linked to enhanced infant protection

Next-gen intranasal vaccine takes on measles, mumps, and multiple COVID-19 variants in one shot

Antigenic cartography decodes the mysteries of SARS-CoV-2 variants and vaccines

Decoding the twist: Coronavirus spike proteins reveal their intricate invasion dance

Novavax vaccine shows resilient defense against symptomatic COVID-19 despite Omicron challenge

COVID-19's ripple effect: South African TB diagnostics take a hit

Nirmatrelvir and ritonavir combo cuts COVID-19 risks for high-vulnerability groups

Protein recombinant vaccine NVX-CoV2373 confers protection during Omicron dominant period in Italy

Inhaled nitric oxide shows promise as treatment for COVID-19 respiratory failure

Why are most Americans skipping the COVID-19 booster?

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in